Adipotide (FTPP) 10mg
For Research Purposes Only – Not for Human Use

Adipotide is a synthetic peptide designed to target obesity in animal research. Scientists developed it to explore vascular targeting in metabolic studies. It selectively binds to blood vessels in white adipose tissue. This action triggers apoptosis, reducing fat deposits in preclinical models.

Researchers studied Adipotide in rats and primates. Key findings include:

• Significant weight loss in obese animal models
• Reduced visceral and subcutaneous fat mass
• Improved insulin sensitivity and glucose tolerance
• No adverse impact on lean body mass
• Targeted vascular disruption in adipose tissue

Studies show that Adipotide administration leads to rapid fat reduction. Animals receiving the peptide ate less and lost more weight. The effects were most pronounced in high-fat diet models. Scientists observed no muscle loss, which supports its specificity.

One study reported potential renal toxicity in higher doses. Researchers must monitor kidney function in long-term trials. More data is needed to assess safety and dosing protocols.

Adipotide is not intended for weight loss, human use, or veterinary applications. It is strictly for laboratory research. Handle all peptides with proper safety equipment. Store in a cool, dry place away from light.